Private Equity Firm • Multi-Strategy • Asia

Taizhou China Medical City New Drug Fund Management

AUM

Not publicly reported

Estimated Dry Powder

$180.2M

Fund Size (Latest)

Taizhou Pharmaceutical City Great Health Industry Fund

$225.6M

Estimated Cheque Size

$431.7K-$4.3M

Stages

Seed
Series A
Series B

Fund Details

Year Established

2016

Website

Room 1506, Building C2, CMC Building, No. 1 Yaocheng Avenue,Gaogang District, Taizhou City, Jiangsu Province, China, Asia

HQ Phone

+86 (0)523 8681 0020

About

Taizhou China Medical City New Drug Fund Management is a private equity firm based in Taizhou, China. It is a captive arm of Taizhou Pharmaceuticals High-tech District Huayin Financial Investment Co., Ltd. The firm focuses on venture opportunities. It invests in a diversified range of industries, including energy, healthcare, and raw materials in China.

HQ Map

No mappable locations available.

Locations

Room 1506, Building C2, CMC Building, No. 1 Yaocheng Avenue,Gaogang District, Taizhou City, Jiangsu Province, China, Asia

Tel: +86 (0)523 8681 0020View map